Aura Historical Cash Flow

AURA Stock  USD 8.95  0.08  0.89%   
Analysis of Aura Biosciences cash flow over time is an excellent tool to project Aura Biosciences future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Stock Based Compensation of 9.2 M or Change In Working Capital of 4.7 M as it is a great indicator of Aura Biosciences ability to facilitate future growth, repay debt on time or pay out dividends.
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Aura Biosciences latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Aura Biosciences is a good buy for the upcoming year.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aura Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For information on how to trade Aura Stock refer to our How to Trade Aura Stock guide.

About Aura Cash Flow Analysis

The Cash Flow Statement is a financial statement that shows how changes in Aura balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Aura's non-liquid assets can be easily converted into cash.

Aura Biosciences Cash Flow Chart

At present, Aura Biosciences' Stock Based Compensation is projected to increase significantly based on the last few years of reporting. The current year's Change In Working Capital is expected to grow to about 4.7 M, whereas Sale Purchase Of Stock is forecasted to decline to about 69.7 M.

Stock Based Compensation

Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.

Begin Period Cash Flow

The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.

Depreciation

Depreciation indicates how much of Aura Biosciences value has been used up. For tax purposes Aura Biosciences can deduct the cost of the tangible assets it purchases as business expenses. However, Aura Biosciences must depreciate these assets in accordance with IRS rules about how and when the deduction may be taken, and how long it will last. The systematic allocation of the cost of a tangible asset over its useful life.

Dividends Paid

The total amount of dividends that a company has paid out to its shareholders over a specific period.

Capital Expenditures

Capital Expenditures are funds used by Aura Biosciences to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Aura Biosciences operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.
Most accounts from Aura Biosciences' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Aura Biosciences current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aura Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For information on how to trade Aura Stock refer to our How to Trade Aura Stock guide.At present, Aura Biosciences' Stock Based Compensation is projected to increase significantly based on the last few years of reporting. The current year's Change In Working Capital is expected to grow to about 4.7 M, whereas Sale Purchase Of Stock is forecasted to decline to about 69.7 M.
 2023 2024 (projected)
Capital Expenditures709K1.1M
Dividends Paid35.8M31.8M

Aura Biosciences cash flow statement Correlations

-0.550.090.140.67-0.69-0.180.560.75-0.5-0.44-0.740.98-0.680.880.70.46-0.570.29
-0.550.620.13-0.880.890.15-0.97-0.860.680.710.81-0.480.88-0.52-0.910.120.96-0.21
0.090.620.59-0.660.63-0.24-0.64-0.530.740.690.480.20.650.28-0.630.620.73-0.52
0.140.130.59-0.410.37-0.9-0.06-0.040.650.04-0.040.080.420.32-0.34-0.050.34-0.65
0.67-0.88-0.66-0.41-1.00.130.860.91-0.93-0.77-0.870.6-1.00.481.0-0.04-0.970.57
-0.690.890.630.37-1.0-0.08-0.87-0.920.910.780.88-0.620.99-0.53-1.00.020.97-0.53
-0.180.15-0.24-0.90.13-0.08-0.21-0.23-0.390.320.35-0.05-0.16-0.350.060.35-0.040.58
0.56-0.97-0.64-0.060.86-0.87-0.210.91-0.69-0.8-0.850.46-0.870.460.89-0.21-0.940.3
0.75-0.86-0.53-0.040.91-0.92-0.230.91-0.78-0.9-0.970.62-0.910.550.93-0.16-0.90.47
-0.50.680.740.65-0.930.91-0.39-0.69-0.780.720.71-0.430.93-0.2-0.890.090.86-0.8
-0.440.710.690.04-0.770.780.32-0.8-0.90.720.91-0.260.75-0.22-0.770.570.77-0.45
-0.740.810.48-0.04-0.870.880.35-0.85-0.970.710.91-0.60.85-0.59-0.880.220.84-0.35
0.98-0.480.20.080.6-0.62-0.050.460.62-0.43-0.26-0.6-0.620.910.630.64-0.50.24
-0.680.880.650.42-1.00.99-0.16-0.87-0.910.930.750.85-0.62-0.48-0.990.00.97-0.6
0.88-0.520.280.320.48-0.53-0.350.460.55-0.2-0.22-0.590.91-0.480.540.54-0.44-0.16
0.7-0.91-0.63-0.341.0-1.00.060.890.93-0.89-0.77-0.880.63-0.990.54-0.02-0.980.51
0.460.120.62-0.05-0.040.020.35-0.21-0.160.090.570.220.640.00.54-0.020.13-0.04
-0.570.960.730.34-0.970.97-0.04-0.94-0.90.860.770.84-0.50.97-0.44-0.980.13-0.44
0.29-0.21-0.52-0.650.57-0.530.580.30.47-0.8-0.45-0.350.24-0.6-0.160.51-0.04-0.44
Click cells to compare fundamentals

Aura Biosciences Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Aura Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Aura Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Aura Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Aura Biosciences Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aura Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For information on how to trade Aura Stock refer to our How to Trade Aura Stock guide.
You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aura Biosciences. If investors know Aura will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aura Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.73)
Return On Assets
(0.30)
Return On Equity
(0.51)
The market value of Aura Biosciences is measured differently than its book value, which is the value of Aura that is recorded on the company's balance sheet. Investors also form their own opinion of Aura Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Aura Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aura Biosciences' market value can be influenced by many factors that don't directly affect Aura Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aura Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Aura Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aura Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.